- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Positive Scoping Study Results for Potash West’s Dandaragan Trough Project
Potash West (ASX:PWN) announced the results of a Scoping Study completed on its wholly owned Dandaragan Trough Project in Western Australia. The Study confirms the technical and financial viability for the proposed development of a potash production facility, average revenues per year of A$365 million and an NPV of A$808 million.
As quoted in the press release:
Highlights:
- Study confirms the technical & financial viability for the proposed development of a potash production facility based at the Dandaragan Trough Project
- Demonstrates that glauconite resources at Dinner Hill can support a 2.4 M tpa operation over a +60 year operational life
- Confirms the ability to produce Sulphate of Potash and other valuable products through a proprietary processing method
- Average Revenues per year of A$365 million
- Estimated average annual cash costs of A$137 million
- IRR of 21%
- NPV of A$808 million
- Progressing towards a Definitive Feasibility Study
The Scoping Study (+/- 35% accuracy) demonstrates the robust nature of Potash West’s proprietary K-Max processing process and provides Potash West with the confidence to move forward towards a Definitive Feasibility Study (DFS).
Click here to read the Potash West (ASX:PWN) press release
Click here to see the Potash West (ASX:PWN) profile.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.